Pediatrix Medical (MD) Accounts Payables (2009 - 2026)

Pediatrix Medical (MD) has reported Accounts Payables for 18 consecutive years, with $301.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables fell 0.5% year-over-year to $301.8 million in Q2 2026; TTM through Jun 2026 was $301.8 million, a 0.5% decrease from a year earlier, with the FY2025 full-year figure at $419.5 million, up 5.23% from the prior year.
• Accounts Payables was $301.8 million for Q2 2026 at Pediatrix Medical, up from $236.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $419.5 million in Q4 2025 and troughed at $207.0 million in Q1 2024.
• A 5-year average of $300.7 million and a median of $302.2 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables dropped 24.26% in 2022 and advanced 13.65% in 2024, its largest moves.
• Over 5 years, Accounts Payables stood at $374.2 million in 2022, then declined by 6.26% to $350.8 million in 2023, then climbed by 13.65% to $398.7 million in 2024, then advanced by 5.23% to $419.5 million in 2025, then decreased by 28.05% to $301.8 million in 2026.
• The last three Accounts Payables figures came in at $301.8 million (Q2 2026), $236.9 million (Q1 2026), and $419.5 million (Q4 2025), per Business Quant data.